Article info
PDFShort report
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing
- Correspondence to Professor Carla Meyer-Massetti, Department of General Internal Medicine, Clinical Pharmacology and Toxicology, University Hospital of Bern – Inselspital Bern, Bern, Bern, Switzerland; carla.meyer-massetti{at}extern.insel.ch
Citation
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing
Publication history
- Received May 2, 2022
- Accepted September 26, 2022
- First published October 14, 2022.
Article Versions
- Previous version (14 October 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.